Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)

NCT01589185 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia Due to Staphylococcus Aureus

Interventions

DRUG: KBSA301
DRUG: Placebo

Sponsor

Aridis Pharmaceuticals, Inc.